{"id":11872,"date":"2026-10-20T18:03:05","date_gmt":"2026-10-20T22:03:05","guid":{"rendered":"https:\/\/crassulapharma.com\/?page_id=11872"},"modified":"2026-10-22T13:30:22","modified_gmt":"2026-10-22T17:30:22","slug":"epirox","status":"publish","type":"page","link":"https:\/\/crassulapharma.com\/es\/epirox\/","title":{"rendered":"Epirox"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"11872\" class=\"elementor elementor-11872\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5301239 e-con-full e-flex e-con e-parent\" data-id=\"5301239\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-6261cb1 elementor-widget elementor-widget-html\" data-id=\"6261cb1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<!doctype html>\n<html lang=\"en\">\n<head>\n<meta charset=\"utf-8\">\n<meta name=\"viewport\" content=\"width=device-width, initial-scale=1\">\n<title>Epirox (Ceftriaxone sodium) \u2013 Crassula<\/title>\n<meta name=\"description\" content=\"Ceftriaxone 1G is a broad-spectrum cephalosporin antibiotic, presented as a powder for injectable solution, for both intravenous (IV) and intramuscular (IM) use.\">\n<link rel=\"preload\" href=\"fonts\/poppins-latin-600-normal.woff2\" as=\"font\" type=\"font\/woff2\" crossorigin>\n<link rel=\"preload\" href=\"fonts\/ibm-plex-sans-latin-400-normal.woff2\" as=\"font\" type=\"font\/woff2\" crossorigin>\n<style>\n@font-face{font-family:\"Poppins\";font-weight:500;font-style:normal;font-display:swap;src:url(fonts\/poppins-latin-500-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"Poppins\";font-weight:600;font-style:normal;font-display:swap;src:url(fonts\/poppins-latin-600-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"IBM Plex Sans\";font-weight:400;font-style:normal;font-display:swap;src:url(fonts\/ibm-plex-sans-latin-400-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"IBM Plex Sans\";font-weight:500;font-style:normal;font-display:swap;src:url(fonts\/ibm-plex-sans-latin-500-normal.woff2) format(\"woff2\")}\n\n:root{\n  --teal-deep:#302304; --teal-head:#4f3b08; --teal:#7a5a0c; --teal-2:#94700f; --teal-3:#4f3b08;\n  --red:#d0904a; --accent-text:#a0662a; --green:#e3ba1b;\n  --action-teal:#7a5a0c; --ink:#2f2406; --ink-muted:#6b6150; --surface:#fbf8ef; --note:#fbf8ef;\n  --line:#efe6d0;\n  --ease-out:cubic-bezier(.23,1,.32,1);\n  --font-head:\"Poppins\",system-ui,sans-serif;\n  --font-body:\"IBM Plex Sans\",system-ui,sans-serif;\n  --cx-gutter:clamp(20px,5vw,48px);\n  --cx-max:1120px;\n}\n*{box-sizing:border-box;margin:0}\nhtml{scroll-behavior:smooth;scroll-padding-top:24px;-webkit-text-size-adjust:100%}\nbody{font-family:var(--font-body);font-size:17px;line-height:1.6;color:var(--ink);background:#fff;-webkit-font-smoothing:antialiased;text-rendering:optimizeLegibility}\nimg{max-width:100%;height:auto;display:block}\na{color:var(--action-teal)}\n:focus-visible{outline:2px solid var(--action-teal);outline-offset:2px;border-radius:6px}\n.skip{position:absolute;left:12px;top:-60px;background:var(--ink);color:#fff;padding:10px 16px;border-radius:999px;z-index:100;text-decoration:none;font-family:var(--font-head);font-weight:500}\n.skip:focus{top:12px}\n.cx-wrap{width:100%;max-width:var(--cx-max);margin-inline:auto;padding-inline:var(--cx-gutter)}\n\n\/* Buttons *\/\n.btn{white-space:nowrap;display:inline-flex;align-items:center;justify-content:center;gap:8px;min-height:48px;padding:16px 28px;border-radius:6px;font:500 16px\/1 var(--font-head);text-decoration:none;cursor:pointer;border:1.5px solid transparent;\n  transition:background-color 150ms var(--ease-out),transform 150ms var(--ease-out),box-shadow 150ms var(--ease-out),color 150ms var(--ease-out)}\n.btn:active{transform:scale(.97)}\n.btn-primary{background:#fff;color:var(--teal-deep)}\n.btn-secondary{background:transparent;border-color:rgba(255,255,255,.85);color:#fff}\n.btn-sm{padding:12px 22px;min-height:48px;font-size:15px}\n@media (hover:hover) and (pointer:fine){\n  .btn-primary:hover{background:#fbefe3;transform:translateY(-2px)}\n  .btn-secondary:hover{background:#fff;color:var(--teal-deep);transform:translateY(-2px)}\n}\n\n\/* Hero *\/\n.hero{position:relative;background:linear-gradient(125deg,#302304 0%,#4f3b08 50%,#94700f 100%);overflow:hidden;isolation:isolate;color:#fff}\n.hero::before{content:\"\";position:absolute;inset:0;z-index:-1;background:repeating-linear-gradient(115deg,rgba(255,255,255,.045) 0 1px,transparent 1px 46px)}\n.hero canvas{position:absolute;inset:0;width:100%;height:100%;z-index:-1;pointer-events:none}\n.hero::after{content:\"\";position:absolute;left:-6%;right:-6%;bottom:-1px;height:clamp(36px,6vw,70px);background:#fff;border-radius:50% 50% 0 0\/100% 100% 0 0}\n.hero .cx-wrap{display:grid;grid-template-columns:1fr 1fr;align-items:center;gap:clamp(24px,4vw,48px);padding-block:clamp(50px,8vw,50px) clamp(96px,11vw,132px)}\n.tag{display:inline-block;font:500 12px\/1 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:#fff;border:1px solid rgba(255,255,255,.4);border-radius:6px;padding:11px 16px;background:rgba(255,255,255,.08);margin-bottom:28px}\nh1{font:600 clamp(40px,7vw,64px)\/1.08 var(--font-head);letter-spacing:-.02em;color:#fff}\nh1 sup{font-size:.34em;vertical-align:top;position:relative;top:.55em;margin-left:.08em;letter-spacing:0}\n.generic{font:500 clamp(22px,3vw,28px)\/1.3 var(--font-head);color:rgba(255,255,255,.88);margin-top:10px}\n.strengths{display:flex;gap:10px;margin-top:26px;flex-wrap:wrap}\n.chip{font:600 20px\/1 var(--font-head);padding:12px 20px;border-radius:12px;color:#fff;font-variant-numeric:tabular-nums}\n.chip.t{background:#fff;color:var(--teal-head)}.chip.g{background:var(--red)}\n.cta-row{display:flex;gap:12px;flex-wrap:wrap;margin-top:36px}\n.hero-art{position:relative;width:100%;display:grid;place-items:center}\n.hero-art img{width:100%;max-width:640px;height:auto}\n@media (max-width:860px){.hero .cx-wrap{grid-template-columns:1fr}.hero-art{max-width:600px;width:100%;margin:0 auto}}\n\n\/* Spec strip *\/\n.specs{margin-top:-70px;position:relative;z-index:2}\n.specs ul{list-style:none;padding:0;display:grid;grid-template-columns:repeat(4,1fr);background:#fff;border:1px solid var(--line);border-radius:20px;box-shadow:0 14px 34px -18px rgba(48,35,4,.30)}\n.specs ul{overflow:hidden}\n.specs li{position:relative;transition:background-color 250ms var(--ease-out),transform 250ms var(--ease-out);display:flex;align-items:center;gap:14px;padding:22px 24px;border-left:1px solid var(--line)}\n.specs li:first-child{border-left:0}\n.specs li::after{content:\"\";position:absolute;left:0;right:0;bottom:0;height:3px;background:linear-gradient(90deg,var(--teal-2),var(--green));transform:scaleX(0);transform-origin:left;transition:transform 350ms var(--ease-out)}\n.specs .ico{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out),box-shadow 300ms var(--ease-out)}\n.specs dd{transition:transform 300ms var(--ease-out),color 250ms var(--ease-out)}\n@media (hover:hover){\n  .specs li:hover{background:var(--note)}\n  .specs li:hover::after{transform:scaleX(1)}\n  .specs li:hover .ico{transform:translateY(-3px) scale(1.12) rotate(-6deg);background:var(--teal-deep);box-shadow:0 10px 18px -8px rgba(48,35,4,.55)}\n  .specs li:hover dd{color:var(--teal);transform:translateX(3px)}\n}\n.ico{flex:none;width:42px;height:42px;border-radius:50%;background:var(--action-teal);display:grid;place-items:center;color:#fff}\n.ico svg{width:20px;height:20px;stroke:currentColor;fill:none;stroke-width:1.8;stroke-linecap:round;stroke-linejoin:round}\n.specs dt{font:500 11px\/1.2 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:var(--ink-muted)}\n.specs dd{font:600 15.5px\/1.3 var(--font-head);margin-top:4px;color:var(--ink)}\n@media (max-width:900px){.specs ul{grid-template-columns:1fr 1fr}.specs li:nth-child(3){border-left:0}.specs li:nth-child(n+3){border-top:1px solid var(--line)}}\n@media (max-width:480px){.specs ul{grid-template-columns:1fr}.specs li{border-left:0!important}.specs li+li{border-top:1px solid var(--line)}}\n\n\/* Sections *\/\nsection{padding-block:clamp(56px,8vw,96px)}\n.h2{color:var(--teal-head);display:flex;align-items:center;gap:14px;font:600 clamp(28px,4vw,36px)\/1.15 var(--font-head);letter-spacing:-.01em;margin-bottom:28px}\n.h2::before{content:\"\";flex:none;width:6px;align-self:stretch;min-height:1.1em;border-radius:4px;background:linear-gradient(var(--teal-2),var(--green))}\n.prose p{max-width:68ch;color:var(--ink)}\n.prose p+p{margin-top:14px}\n.prose strong{font-weight:500;color:var(--action-teal);font-family:var(--font-head)}\n.about{padding-top:clamp(64px,9vw,104px)}\n\n\/* Indications *\/\n.indications{background:#fff;padding-top:0}\n.cards{display:grid;grid-template-columns:repeat(2,1fr);gap:20px}\n.card{background:var(--surface);border:1px solid var(--line);border-radius:20px;padding:28px;transition:transform 250ms var(--ease-out),box-shadow 250ms var(--ease-out),border-color 250ms var(--ease-out)}\n.card{position:relative;overflow:hidden}\n.card::after{content:\"\";position:absolute;left:0;right:0;bottom:0;height:4px;background:linear-gradient(90deg,var(--teal-2),var(--green));transform:scaleX(0);transform-origin:left;transition:transform 400ms var(--ease-out)}\n.card .ico{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out),color 250ms var(--ease-out)}\n@media (hover:hover){\n  .card:hover{transform:translateY(-8px);box-shadow:0 24px 40px -22px rgba(48,35,4,.45);border-color:#dccfa8;background:#fff}\n  .card:hover::after{transform:scaleX(1)}\n  .card:hover .ico{background:var(--teal);color:#fff;transform:rotate(-8deg) scale(1.12)}\n}\n.card .ico{width:38px;height:38px;background:#fff;color:var(--action-teal);border:1px solid var(--line);border-radius:12px;margin-bottom:18px}\n.card h3{color:var(--teal-head);font:600 19px\/1.3 var(--font-head);color:var(--ink);margin-bottom:10px}\n.card p{color:var(--ink-muted);font-size:16.5px}\n.card em{font-style:italic}\n@media (max-width:760px){.cards{grid-template-columns:1fr}}\n\n\/* Presentations *\/\n.presentations{background:var(--surface)}\n.pres{display:grid;grid-template-columns:1fr 1fr;gap:20px}\n.pcard{display:flex;align-items:center;gap:24px;background:#fff;border:1px solid var(--line);border-radius:20px;padding:26px 28px;position:relative;overflow:hidden;transition:transform 250ms var(--ease-out),box-shadow 250ms var(--ease-out)}\n.pcard::before{content:\"\";position:absolute;left:0;top:0;bottom:0;width:6px;background:var(--c)}\n.pcard::before{transition:width 300ms var(--ease-out)}\n.dose{transition:transform 350ms var(--ease-out)}\n@media (hover:hover){\n  .pcard:hover{transform:translateY(-6px);box-shadow:0 24px 40px -22px rgba(48,35,4,.45)}\n  .pcard:hover::before{width:14px}\n  .pcard:hover .dose{transform:scale(1.08) translateX(4px)}\n}\n.dose{font:600 clamp(40px,6vw,52px)\/1 var(--font-head);color:var(--c);letter-spacing:-.02em;white-space:nowrap}\n.dose small{font:500 18px\/1 var(--font-head);letter-spacing:0;margin-left:4px}\n.pcard h3{color:var(--teal-head);font:600 17px\/1.35 var(--font-head);margin-bottom:6px}\n.pcard p{color:var(--ink-muted);font-size:16px;line-height:1.5}\n@media (max-width:760px){.pres{grid-template-columns:1fr}}\n\n\/* Mechanism *\/\n.mech-intro{max-width:78ch;margin-bottom:44px}\n.mech-intro strong{font-weight:500;color:var(--action-teal);font-family:var(--font-head)}\n.mech-grid{display:grid;grid-template-columns:1.1fr .9fr;gap:clamp(28px,5vw,64px);align-items:start}\n.steps{list-style:none;padding:0;position:relative}\n.steps::before{content:\"\";position:absolute;left:19px;top:20px;bottom:30px;width:2px;background:linear-gradient(var(--action-teal),rgba(148,112,15,.08));transform-origin:top;transform:scaleY(var(--line,0));transition:transform 900ms var(--ease-out)}\n.steps li{position:relative;padding-left:64px;padding-bottom:34px;transition:transform 300ms var(--ease-out)}\n.num{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out)}\n.steps h3{transition:color 250ms var(--ease-out)}\n@media (hover:hover){.steps li:hover{transform:translateX(6px)}.steps li:hover .num{transform:scale(1.18);background:var(--teal-deep)}.steps li:hover h3{color:var(--teal)}}\n.steps li:last-child{padding-bottom:0}\n.num{position:absolute;left:0;top:0;width:40px;height:40px;border-radius:50%;background:var(--action-teal);color:#fff;display:grid;place-items:center;font:600 16px\/1 var(--font-head);box-shadow:0 0 0 5px #fff}\n.steps h3{color:var(--teal-head);font:600 19px\/1.3 var(--font-head);color:var(--ink);margin:6px 0 6px}\n.steps p{color:var(--ink-muted)}\n@media (max-width:900px){.mech-grid{grid-template-columns:1fr}}\n\n\/* Flow diagram *\/\n.flow{background:var(--surface);border:1px solid var(--line);border-radius:24px;padding:28px clamp(18px,3vw,32px) 32px;text-align:center}\n.flow-title{font:600 12px\/1 var(--font-body);letter-spacing:.14em;text-transform:uppercase;color:var(--ink-muted);margin-bottom:22px}\n.node{display:block;margin-inline:auto;background:#fff;border:1.5px solid #e8dcbc;border-radius:12px;padding:10px 16px;max-width:300px;font:600 14px\/1.3 var(--font-head);color:var(--ink);opacity:0;transition:border-color 250ms var(--ease-out),box-shadow 250ms var(--ease-out),transform 250ms var(--ease-out)}\n.node small{display:block;font:400 12px\/1.3 var(--font-body);color:var(--ink-muted);margin-top:2px}\n.node.primary{background:var(--action-teal);border-color:var(--action-teal);color:#fff;border-radius:999px;padding:14px 20px;font-size:16px}\n.node.primary small{color:#fff;font-size:12.5px}\n.node.end{background:var(--action-teal);border-color:var(--action-teal);color:#fff;padding:14px 18px;font-size:15px}\n.flow.in .node{opacity:1;animation:rise 450ms var(--ease-out) backwards;animation-delay:calc(var(--i)*220ms)}\n@media (hover:hover){.flow.in .node:hover{transform:translateY(-3px) scale(1.03);border-color:var(--teal);box-shadow:0 10px 20px -12px rgba(48,35,4,.45)}}\n.link-v{display:flex;flex-direction:column;align-items:center;height:30px;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .link-v{opacity:1}\n.link-v::before{content:\"\";flex:1;width:2px;background:var(--action-teal)}\n.link-v::after{content:\"\";width:0;height:0;border:6px solid transparent;border-top:8px solid var(--action-teal);border-bottom:0}\n.link-v.stop::after{border:0;width:22px;height:2px;background:var(--red)}\n.link-v.stop::before{background:var(--red)}\n.link-v.stop span{position:absolute;left:calc(50% + 14px);top:50%;transform:translateY(-50%);font:400 11.5px\/1 var(--font-body);color:var(--accent-text)}\n.pair{display:grid;grid-template-columns:1fr 1fr;gap:10px;max-width:340px;margin-inline:auto}\n.pair .node{max-width:none;font-size:13px;padding:10px 10px}\n.fork{max-width:340px;height:28px;margin-inline:auto;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .fork{opacity:1}\n.fork::before{content:\"\";position:absolute;left:25%;right:25%;top:0;height:14px;border:2px solid var(--action-teal);border-bottom:0;border-radius:0}\n.fork::after{content:\"\";position:absolute;left:50%;top:-14px;height:14px;width:2px;background:var(--action-teal)}\n.fork i{position:absolute;top:14px;width:0;height:0;border:6px solid transparent;border-top:8px solid var(--action-teal);border-bottom:0}\n.fork i:first-child{left:calc(25% - 6px)}.fork i:last-child{right:calc(25% - 6px)}\n.pair-wrap{display:grid;gap:10px}\n.down-merge{margin-top:2px}\n\n\n\/* Gasflum additions *\/\n.pcard.wide{display:grid;grid-template-columns:auto 1fr;gap:clamp(20px,4vw,48px)}\n.pgrid{display:grid;grid-template-columns:repeat(3,1fr);gap:20px}\n.pgrid dt{font:500 11px\/1.2 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:var(--ink-muted)}\n.pgrid dd{font:600 16px\/1.35 var(--font-head);color:var(--teal-head);margin-top:6px}\n@media (max-width:760px){.pcard.wide{grid-template-columns:1fr;gap:16px}.pgrid{grid-template-columns:1fr}}\n.dn{color:var(--red);font-weight:600}\n.node.end.clock{display:flex;align-items:center;justify-content:center;gap:12px;max-width:260px;margin-top:14px;text-align:left;padding:12px 18px}\n.node.end.clock svg{flex:none;width:34px;height:34px;padding:7px;border-radius:50%;background:var(--red);stroke:#fff;fill:none;stroke-width:2;stroke-linecap:round;stroke-linejoin:round}\n.node.end.clock b{display:block;font:600 15px\/1.2 var(--font-head)}\n.node.end.clock small{color:#fff;opacity:.92;font-size:12px;margin-top:2px}\n.pair{margin-top:0}\n.steps p sup{font-size:.7em;line-height:0}\n\n\n\/* Media + FAQ additions *\/\n.split{display:grid;grid-template-columns:1.1fr .9fr;gap:clamp(28px,5vw,72px);align-items:center}\n.split.rev{grid-template-columns:.9fr 1.1fr}\n.media-wrap{position:relative;isolation:isolate}\n.media-wrap::before{content:\"\";position:absolute;right:-14px;bottom:-14px;width:62%;height:62%;border-radius:26px;background:linear-gradient(135deg,var(--teal-2),var(--green));opacity:.2;z-index:-1;transition:transform 500ms var(--ease-out),opacity 500ms var(--ease-out)}\n.split.rev .media-wrap::before{right:auto;left:-14px}\n.media{position:relative;border-radius:24px;overflow:hidden;aspect-ratio:4\/4;background:var(--surface)}\n.media img{width:100%;height:100%;object-fit:cover;display:block;transition:transform 900ms var(--ease-out)}\n@media (hover:hover){.media-wrap:hover .media img{transform:scale(1.05)}.media-wrap:hover::before{transform:translate(6px,6px);opacity:.32}.split.rev .media-wrap:hover::before{transform:translate(-6px,6px)}}\n@media (max-width:860px){.split,.split.rev{grid-template-columns:1fr}.split.rev .media-wrap{order:2}.media-wrap{max-width:560px}}\n.faq{background:var(--surface)}\n.faq-list{display:grid;gap:12px;max-width:880px}\n.faq-item{background:#fff;border:1px solid var(--line);border-radius:16px;overflow:hidden;transition:border-color 250ms var(--ease-out),box-shadow 250ms var(--ease-out),transform 250ms var(--ease-out)}\n@media (hover:hover){.faq-item:hover{transform:translateY(-2px);border-color:#dccfa8;border-color:color-mix(in srgb,var(--teal-2) 40%,var(--line));box-shadow:0 16px 30px -22px rgba(48,35,4,.4)}}\n.faq-item.open{border-color:var(--teal-2);box-shadow:0 18px 34px -24px rgba(48,35,4,.45)}\n.faq-q{width:100%;display:flex;align-items:center;justify-content:space-between;gap:16px;min-height:48px;padding:20px 24px;background:none;border:0;cursor:pointer;text-align:left;font:600 17px\/1.4 var(--font-head);color:var(--teal-head)}\n.faq-q:focus-visible{outline-offset:-4px}\n.faq-ico{flex:none;width:34px;height:34px;border-radius:10px;background:var(--surface);display:grid;place-items:center;transition:background-color 250ms var(--ease-out),transform 350ms var(--ease-out)}\n.faq-ico svg{width:16px;height:16px;stroke:var(--teal);stroke-width:2.2;stroke-linecap:round;fill:none;transition:stroke 250ms var(--ease-out)}\n.faq-item.open .faq-ico{background:var(--teal);transform:rotate(45deg)}\n.faq-item.open .faq-ico svg{stroke:#fff}\n.faq-a{display:grid;grid-template-rows:0fr;transition:grid-template-rows 350ms var(--ease-out)}\n.faq-item.open .faq-a{grid-template-rows:1fr}\n.faq-a>div{overflow:hidden;visibility:hidden;transition:visibility 0s linear 350ms}\n.faq-item.open .faq-a>div{visibility:visible;transition-delay:0s}\n.faq-a p{padding:0 24px 22px;max-width:70ch;color:var(--ink-muted)}\n.faq-a p+p{padding-top:0;margin-top:-8px}\n\n\n\/* Note with background image *\/\n.note-box.has-bg{position:relative;overflow:hidden;isolation:isolate;border:0;color:#fff;min-height:260px;display:flex;flex-direction:column;justify-content:center;padding:clamp(32px,5vw,64px)}\n.note-box.has-bg .bg{position:absolute;inset:0;z-index:-2;overflow:hidden}\n.note-box.has-bg .bg img{width:100%;height:100%;object-fit:cover;object-position:0% 100%;display:block;transform:scale(1.02);transition:transform 1000ms var(--ease-out)}\n.note-box.has-bg::after{content:\"\";position:absolute;inset:0;z-index:-1;background:linear-gradient(100deg,rgba(var(--ov),.93) 0%,rgba(var(--ov),.86) 60%,rgba(var(--ov),.78) 100%)}\n.note-box.has-bg h3{color:#fff}\n.note-box.has-bg h3 .ico{background:rgba(255,255,255,.16);box-shadow:inset 0 0 0 1px rgba(255,255,255,.28)}\n.note-box.has-bg p{color:#fff;max-width:72ch;font-size:17.5px}\n.note-box.has-bg p::before{background:var(--green)}\n@media (hover:hover){.note-box.has-bg:hover .bg img{transform:scale(1.08)}}\n\/* Rounded-corner fix: clip every layer to the radius so hover scale never squares the corners *\/\n.note-box.has-bg{border-radius:20px;clip-path:inset(0 round 20px)}\n@media (hover:hover){.note-box.has-bg:hover{transform:translate3d(0,-4px,0);box-shadow:none}}\n.note-box.has-bg .bg,.note-box.has-bg .bg img,.note-box.has-bg::after{border-radius:20px}\n.note-box.has-bg .bg img{will-change:transform}\n\n\n\/* Note *\/\n.note{padding-block:0 clamp(40px,6vw,64px)}\n.note-box{background:var(--note);border:1px solid #efe6d0;border-radius:20px;padding:26px clamp(20px,3vw,32px)}\n.note-box{transition:transform 300ms var(--ease-out),box-shadow 300ms var(--ease-out)}\n@media (hover:hover){.note-box:hover{transform:translateY(-4px);box-shadow:0 22px 38px -26px rgba(48,35,4,.5)}}\n.note-box h3{color:var(--teal-head);display:flex;align-items:center;gap:12px;font:600 19px\/1.2 var(--font-head);margin-bottom:12px}\n.note-box h3 .ico{width:38px;height:38px;border-radius:12px;background:var(--action-teal)}\n.note-box p{position:relative;padding-left:20px;color:var(--ink)}\n.note-box p::before{content:\"\";position:absolute;left:0;top:.7em;width:8px;height:8px;border-radius:50%;background:var(--teal-2)}\n\n\/* Quality *\/\n.quality{padding-top:96px}\n.qbox{border:1px solid var(--line);border-radius:20px;padding:clamp(22px,3vw,34px);box-shadow:0 14px 34px -24px rgba(14,42,51,.25)}\n.qbox h2{font:600 22px\/1.2 var(--font-head);margin-bottom:24px}\n.qgrid{display:grid;grid-template-columns:auto 1fr 1fr;gap:clamp(20px,3vw,40px);align-items:center}\n.gmp{width:112px;height:112px;object-fit:contain;flex:none;filter:drop-shadow(0 6px 12px rgba(48,35,4,.18));transition:transform 500ms var(--ease-out),filter 500ms var(--ease-out)}\n@media (hover:hover){.gmp:hover{transform:scale(1.08);filter:drop-shadow(0 10px 18px rgba(48,35,4,.24))}}\n.check{display:flex;gap:14px;color:var(--ink-muted);font-size:16px;line-height:1.55}\n.check{transition:transform 300ms var(--ease-out)}\n@media (hover:hover){.check:hover{transform:translateY(-4px)}.check:hover svg{transform:scale(1.18) rotate(-6deg)}}\n.check svg{transition:transform 300ms var(--ease-out);flex:none;width:26px;height:26px;stroke:var(--green);fill:none;stroke-width:1.8;stroke-linecap:round;stroke-linejoin:round;margin-top:2px}\n@media (max-width:900px){.qgrid{grid-template-columns:1fr;align-items:start}}\n\n\/* Reveal *\/\n.rv{opacity:0}\n.rv.in{opacity:1;animation:rise 600ms var(--ease-out) backwards;animation-delay:calc(var(--d,0)*80ms)}\n@keyframes rise{from{opacity:0;transform:translateY(18px)}to{opacity:1;transform:none}}\n.hero-art img{opacity:0;transition:opacity 700ms var(--ease-out),transform 900ms var(--ease-out)}\n.loaded .hero-art img{opacity:1;transform:none}\n@keyframes bob{0%,100%{translate:0 0}50%{translate:0 -8px}}\n.hero-art img{transform:translate(30px,24px) rotate(2deg)}\n.loaded .hero-art img{animation:bob 7s ease-in-out 1.2s infinite}\n.hero-copy>*{opacity:0;transform:translateY(14px);transition:opacity 600ms var(--ease-out),transform 600ms var(--ease-out)}\n.loaded .hero-copy>*{opacity:1;transform:none}\n.loaded .hero-copy>:nth-child(2){transition-delay:70ms}.loaded .hero-copy>:nth-child(3){transition-delay:140ms}.loaded .hero-copy>:nth-child(4){transition-delay:210ms}.loaded .hero-copy>:nth-child(5){transition-delay:280ms}\n\n@media (prefers-reduced-motion:reduce){\n  html{scroll-behavior:auto}\n  *,*::before,*::after{animation:none!important;transition-duration:.01ms!important;transition-delay:0ms!important}\n  .rv,.hero-copy>*,.hero-art img,.node,.link-v,.fork,.join{opacity:1!important;transform:none!important}\n  .steps{--line:1!important}\n}\n.no-js .rv,.no-js .hero-copy>*,.no-js .hero-art img,.no-js .node,.no-js .link-v,.no-js .fork,.no-js .join{opacity:1;transform:none}\n.no-js .steps{--line:1}\n\n\/* Epirox additions *\/\n.tag{line-height:1.5}\n.cards .card.wide{grid-column:1\/-1}\n.cards .card.wide p{max-width:none}\n.card-h{display:flex;align-items:center;gap:14px;margin-bottom:10px}\n.card-h .ico{margin-bottom:0}\n.card-h h3{margin-bottom:0}\n.steps li{padding-bottom:28px}\n.pair.col2{margin-top:0}\n.pair.col2 .link-v{height:auto;min-height:30px;align-self:stretch}\n.pair.col2 .gap-l::after{display:none}\n.pair.col2 .gap-l{height:auto;align-self:stretch}\n.join{max-width:340px;height:16px;margin-inline:auto;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .join{opacity:1}\n.join::before{content:\"\";position:absolute;left:25%;right:25%;bottom:0;height:16px;border:2px solid var(--action-teal);border-top:0}\n.join::after{content:\"\";position:absolute;left:50%;bottom:-14px;height:14px;width:2px;background:var(--action-teal)}\n.node.end small{color:#fff;opacity:.92}\n.pair .node small{font-size:11px}\n.chip.g{background:#d0904a;color:#fff}\n.check svg{stroke:#5ba646}\n.subh{font:600 italic 19px\/1.3 var(--font-head);color:var(--teal-head);margin:22px 0 8px}\n.card ul{list-style:none;padding:0;display:grid;gap:10px}\n.card li{position:relative;padding-left:20px;color:var(--ink-muted);font-size:16.5px}\n.card li::before{content:\"\";position:absolute;left:0;top:.65em;width:8px;height:8px;border-radius:50%;background:var(--teal-2)}\n.cards.c3{grid-template-columns:repeat(3,1fr)}\n@media (max-width:900px){.cards.c3{grid-template-columns:1fr}}\n.lead{max-width:80ch;margin-bottom:28px;color:var(--ink)}\n.cards.c2{margin-bottom:20px}\n.note-box.has-bg ul{list-style:none;padding:0;display:grid;gap:12px;max-width:80ch}\n.note-box.has-bg li{position:relative;padding-left:20px;font-size:17.5px;line-height:1.6;color:#fff}\n.note-box.has-bg li::before{content:\"\";position:absolute;left:0;top:.7em;width:8px;height:8px;border-radius:50%;background:#c9d3e3}\n.specs dd{overflow-wrap:break-word}\n[type=\"button\"]:hover{background-color:transparent;color:var(--teal-head)}\n[type=\"button\"]:focus{background-color:transparent;color:var(--teal-head)}\n<\/style>\n<script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"FAQPage\", \"mainEntity\": [{\"@type\": \"Question\", \"name\": \"What is Epirox?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Ceftriaxone 1G (Ceftriaxone Sodium) for Intravenous and Intramuscular Use. Ceftriaxone 1G is a broad-spectrum cephalosporin antibiotic, presented as a powder for injectable solution, for both intravenous (IV) and intramuscular (IM) use. This medication is designed for the treatment of severe bacterial infections, offering high efficacy against a wide variety of gram-positive and gram-negative pathogens.\"}}, {\"@type\": \"Question\", \"name\": \"What is Epirox indicated for?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Ceftriaxone 1G is indicated for the treatment of various bacterial infections in adults and children, including respiratory infections, skin and soft tissue infections, urinary tract infections, intra-abdominal infections, uncomplicated gonorrhea caused by susceptible Neisseria gonorrhoeae, and bacterial meningitis.\"}}, {\"@type\": \"Question\", \"name\": \"How does Epirox work?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Ceftriaxone is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis. It shows high penetration into body tissues and fluids, including cerebrospinal fluid.\"}}, {\"@type\": \"Question\", \"name\": \"How is Epirox dosed and administered?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Standard dose for adults and children over 12 years: 1G of Ceftriaxone administered once daily or divided into two doses of 500 mg every 12 hours. For severe or critical infections, the dose may be increased to 2-4 G per day. The duration of treatment varies according to the severity and type of infection, but is generally 5 to 14 days. For IV administration, dissolve in sterile solution and administer slowly over at least 30 minutes. For IM administration, dilute in 1% lidocaine to reduce pain at the injection site.\"}}, {\"@type\": \"Question\", \"name\": \"What are the benefits of Ceftriaxone 1G?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Broad spectrum of antibacterial activity. Convenient once-daily dosing facilitates treatment compliance. Broad-spectrum antibacterial activity against susceptible organisms.\"}}, {\"@type\": \"Question\", \"name\": \"What are the clinical considerations for Epirox?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Evaluate the sensitivity of the causative microorganism before starting treatment. No dosage adjustment is generally necessary in patients with isolated renal or hepatic impairment. Use caution in patients with significant renal and hepatic dysfunction. Monitor the response to treatment and adjust therapy as necessary.\"}}, {\"@type\": \"Question\", \"name\": \"What are the safety and precautionary measures for Epirox?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Caution in patients with a history of allergic reactions to beta-lactam antibiotics. Monitor for signs of pseudomembranous colitis and other gastrointestinal adverse reactions. Do not use in hyperbilirubinemic neonates. Ceftriaxone is contraindicated in neonates \u226428 days who require or are expected to require calcium-containing IV solutions.\"}}, {\"@type\": \"Question\", \"name\": \"Which strength and presentation is available?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Epirox contains Ceftriaxone sodium USP 1.0 g and is presented in a box of 10 and 50 vials, following the United States Pharmacopeia standard.\"}}, {\"@type\": \"Question\", \"name\": \"How is Epirox manufactured?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality. Crassula Pharma certifies that all our products are manufactured in accordance with GMP parameters.\"}}]}<\/script>\n<\/head>\n<body class=\"no-js\">\n<a class=\"skip\" href=\"#main\">Skip to content<\/a>\n<span id=\"top\"><\/span>\n\n\n<main id=\"main\">\n<section class=\"hero\" aria-labelledby=\"h1\" style=\"padding:0\">\n  <canvas id=\"fx\" aria-hidden=\"true\"><\/canvas>\n  <div class=\"cx-wrap\">\n    <div class=\"hero-copy\">\n      <span class=\"tag\">Cephalosporin \u00b7 Powder for Injectable Solution I.V. \/ I.M.<\/span>\n      <h1 id=\"h1\">Epirox<\/h1>\n      <p class=\"generic\">Ceftriaxone sodium<\/p>\n      <div class=\"strengths\" role=\"list\">\n        <span class=\"chip g\" role=\"listitem\">1 g<\/span>\n      <\/div>\n      <div class=\"cta-row\">\n        <a class=\"btn btn-primary\" href=\"#mechanism\">Pharmacological Properties<\/a>\n      <\/div>\n    <\/div>\n    <div class=\"hero-art\">\n      <img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/box-epirox.png\" alt=\"Epirox ceftriaxone sodium 1 g box\" width=\"1109\" height=\"446\" title=\"\">\n    <\/div>\n  <\/div>\n<\/section>\n\n<div class=\"specs\">\n  <div class=\"cx-wrap\">\n    <ul>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><rect x=\"2.5\" y=\"8\" width=\"19\" height=\"8\" rx=\"4\"\/><path d=\"M12 8v8\"\/><\/svg><\/span><dl><dt>Active ingredient<\/dt><dd>Ceftriaxone sodium USP<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 12c-2-3-3.5-4-5.5-4a4 4 0 0 0 0 8c2 0 3.5-1 5.5-4Zm0 0c2 3 3.5 4 5.5 4a4 4 0 0 0 0-8c-2 0-3.5 1-5.5 4Z\"\/><\/svg><\/span><dl><dt>Strength<\/dt><dd>1.0 g<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M21 8 12 3 3 8v8l9 5 9-5V8Z\"\/><path d=\"m3 8 9 5 9-5M12 13v8\"\/><\/svg><\/span><dl><dt>Presentation<\/dt><dd>Box of 10 and 50 vials<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><rect x=\"5\" y=\"3\" width=\"14\" height=\"18\" rx=\"3\"\/><path d=\"M9 8h6M9 12h6M9 16h3\"\/><\/svg><\/span><dl><dt>Standard<\/dt><dd>USP<\/dd><\/dl><\/li>\n    <\/ul>\n  <\/div>\n<\/div>\n\n<section class=\"about\" aria-labelledby=\"what\">\n  <div class=\"cx-wrap split\">\n    <div class=\"prose rv\">\n    <h2 class=\"h2\" id=\"what\">What is Epirox?<\/h2>\n    <p><strong>Ceftriaxone 1G<\/strong> (Ceftriaxone Sodium) for Intravenous and Intramuscular Use.<\/p>\n    <h3 class=\"subh\">Product Description<\/h3>\n    <p>Ceftriaxone 1G is a broad-spectrum cephalosporin antibiotic, presented as a powder for injectable solution, for both intravenous (IV) and intramuscular (IM) use. This medication is designed for the treatment of severe bacterial infections, offering high efficacy against a wide variety of gram-positive and gram-negative pathogens.<\/p>\n    <\/div>\n    <div class=\"media-wrap rv\" style=\"--d:1\"><div class=\"media\"><img loading=\"lazy\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/info-epirox.jpg\" alt=\"\" width=\"1600\" height=\"1200\" loading=\"lazy\" decoding=\"async\" title=\"\"><\/div><\/div>\n  <\/div>\n<\/section>\n\n<section class=\"indications\" id=\"indications\" aria-labelledby=\"ind\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"ind\">Indications<\/h2>\n    <p class=\"lead rv\">Ceftriaxone 1G is indicated for the treatment of various bacterial infections in adults and children, including:<\/p>\n    <div class=\"cards c3\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M5 9c4-4 10-4 14 0M8 12.500c2.500-2 5.500-2 8 0M11 16c.700-.500 1.300-.500 2 0\"\/><\/svg><\/span><h3>Respiratory Infections<\/h3><\/div>\n        <p>Pneumonia, acute bronchitis and bacterial exacerbations of chronic bronchitis.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3s6 6.500 6 11a6 6 0 0 1-12 0c0-4.500 6-11 6-11Z\"\/><\/svg><\/span><h3>Skin and Soft Tissue Infections<\/h3><\/div>\n        <p>Cellulitis, erysipelas and infected wounds.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M9 3h6M10 3v6l-4.500 9a2 2 0 0 0 1.800 3h9.400a2 2 0 0 0 1.800-3L14 9V3\"\/><\/svg><\/span><h3>Urinary Tract Infections<\/h3><\/div>\n        <p>Cystitis, pyelonephritis and prostatitis.<\/p>\n      <\/article>\n    <\/div>\n    <div class=\"cards c3\" style=\"margin-top:20px\">\n      <article class=\"card rv\" style=\"--d:3\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9\"\/><path d=\"M12 8v8M8 12h8\"\/><\/svg><\/span><h3>Intra-abdominal Infections<\/h3><\/div>\n        <p>Peritonitis and other infections of the biliary tract.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:4\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3 4 6v6c0 4.500 3.500 7.500 8 9 4.500-1.500 8-4.500 8-9V6l-8-3Z\"\/><path d=\"m9 12 2 2 4-4\"\/><\/svg><\/span><h3>Treatment of uncomplicated gonorrhea<\/h3><\/div>\n        <p>Caused by susceptible <em>Neisseria gonorrhoeae<\/em>.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:5\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"8\" r=\"4\"\/><path d=\"M8.500 13 7 21l5-3 5 3-1.500-8\"\/><\/svg><\/span><h3>Bacterial Meningitis<\/h3><\/div>\n        <p>Treatment of infections of the central nervous system.<\/p>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"presentations\" id=\"presentations\" aria-labelledby=\"pres\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"pres\">Presentation<\/h2>\n    <article class=\"pcard wide rv\" style=\"--c:#d0904a\">\n      <div class=\"dose\">1.0<small>g<\/small><\/div>\n      <dl class=\"pgrid\">\n        <div><dt>Active ingredient<\/dt><dd>Ceftriaxone sodium USP 1.0 g<\/dd><\/div>\n        <div><dt>Presentation<\/dt><dd>Box of 10 and 50 vials<\/dd><\/div>\n        <div><dt>Standard<\/dt><dd>United States Pharmacopeia<\/dd><\/div>\n      <\/dl>\n    <\/article>\n  <\/div>\n<\/section>\n\n<section id=\"mechanism\" aria-labelledby=\"moa\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"moa\">Pharmacological Properties<\/h2>\n    <div class=\"mech-grid\">\n      <ol class=\"steps\" id=\"steps\">\n        <li class=\"rv\"><span class=\"num\">1<\/span><h3>Beta-Lactam Antibiotic<\/h3><p>Ceftriaxone is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis.<\/p><\/li>\n        <li class=\"rv\"><span class=\"num\">2<\/span><h3>High Tissue Penetration<\/h3><p>High penetration into body tissues and fluids, including cerebrospinal fluid.<\/p><\/li>\n      <\/ol>\n\n      <div class=\"flow\" id=\"flow\" role=\"group\" aria-label=\"How Epirox works\">\n        <p class=\"flow-title\">How Epirox works<\/p>\n        <span class=\"node primary\" style=\"--i:0\">Epirox<small>Ceftriaxone<\/small><\/span>\n        <div class=\"link-v stop\" style=\"--i:1\"><span>inhibits<\/span><\/div>\n        <span class=\"node\" style=\"--i:2\">Bacterial cell wall synthesis<\/span>\n        <div class=\"fork\" style=\"--i:3\"><i><\/i><i><\/i><\/div>\n        <div class=\"pair\">\n          <span class=\"node\" style=\"--i:4\"><b>Broad spectrum<\/b><small>gram-positive &amp; gram-negative<\/small><\/span>\n          <span class=\"node\" style=\"--i:4\"><b>High penetration<\/b><small>tissues, fluids &amp; CSF<\/small><\/span>\n        <\/div>\n        <div class=\"join\" style=\"--i:5\"><\/div>\n        <div style=\"height:14px\"><\/div>\n        <span class=\"node end\" style=\"--i:6;margin-top:0\">Treatment of severe bacterial infections<\/span>\n      <\/div>\n    <\/div>\n\n    <div class=\"cards c3\" style=\"margin-top:56px\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9\"\/><path d=\"M12 7v5l3 2\"\/><\/svg><\/span><h3>Dosage and Administration<\/h3><\/div>\n        <ul><li>Standard dose for adults and children over 12 years: 1G of Ceftriaxone administered once daily or divided into two doses of 500 mg every 12 hours.<\/li><li>For severe or critical infections, the dose may be increased to 2-4 G per day.<\/li><li>The duration of treatment varies according to the severity and type of infection, but is generally 5 to 14 days.<\/li><li>For IV administration, dissolve in sterile solution and administer slowly over at least 30 minutes.<\/li><li>For IM administration, dilute in 1% lidocaine to reduce pain at the injection site.<\/li><\/ul>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><rect x=\"2.500\" y=\"8\" width=\"19\" height=\"8\" rx=\"4\"\/><path d=\"M12 8v8\"\/><\/svg><\/span><h3>Benefits of Ceftriaxone 1G<\/h3><\/div>\n        <ul><li>Broad spectrum of antibacterial activity.<\/li><li>Convenient once-daily dosing facilitates treatment compliance.<\/li><li>Broad-spectrum antibacterial activity against susceptible organisms.<\/li><\/ul>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M9 3h6M10 3v6l-5 9a2 2 0 0 0 1.800 3h10.400a2 2 0 0 0 1.800-3l-5-9V3\"\/><path d=\"M7.500 15h9\"\/><\/svg><\/span><h3>Clinical Considerations<\/h3><\/div>\n        <ul><li>Evaluate the sensitivity of the causative microorganism before starting treatment.<\/li><li>No dosage adjustment is generally necessary in patients with isolated renal or hepatic impairment. Use caution in patients with significant renal and hepatic dysfunction.<\/li><li>Monitor the response to treatment and adjust therapy as necessary.<\/li><\/ul>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"note\" aria-labelledby=\"imp\">\n  <div class=\"cx-wrap\">\n    <div class=\"note-box has-bg rv\" style=\"--ov:48,35,4\">\n      <div class=\"bg\" aria-hidden=\"true\"><img loading=\"lazy\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/info-epirox.jpg\" alt=\"\" width=\"1600\" height=\"1200\" loading=\"lazy\" decoding=\"async\" title=\"\"><\/div>\n      <h3 id=\"imp\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3 2.500 20h19L12 3Z\"\/><path d=\"M12 10v4.500M12 17.200v.1\"\/><\/svg><\/span>Safety and Precautionary Measures<\/h3>\n      <ul>\n        <li>Caution in patients with a history of allergic reactions to beta-lactam antibiotics.<\/li>\n        <li>Monitor for signs of pseudomembranous colitis and other gastrointestinal adverse reactions.<\/li>\n        <li>Do not use in hyperbilirubinemic neonates. Ceftriaxone is contraindicated in neonates \u226428 days who require or are expected to require calcium-containing IV solutions.<\/li>\n      <\/ul>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"faq\" id=\"faq\" aria-labelledby=\"faq-h\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"faq-h\">Frequently Asked Questions<\/h2>\n    <div class=\"faq-list\">\n      <div class=\"faq-item rv\" style=\"--d:0\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q1\" aria-expanded=\"false\" aria-controls=\"faq-a1\"><span>What is Epirox?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a1\" role=\"region\" aria-labelledby=\"faq-q1\"><div><p><strong>Ceftriaxone 1G<\/strong> (Ceftriaxone Sodium) for Intravenous and Intramuscular Use. Ceftriaxone 1G is a broad-spectrum cephalosporin antibiotic, presented as a powder for injectable solution, for both intravenous (IV) and intramuscular (IM) use. This medication is designed for the treatment of severe bacterial infections, offering high efficacy against a wide variety of gram-positive and gram-negative pathogens.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:1\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q2\" aria-expanded=\"false\" aria-controls=\"faq-a2\"><span>What is Epirox indicated for?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a2\" role=\"region\" aria-labelledby=\"faq-q2\"><div><p>Ceftriaxone 1G is indicated for the treatment of various bacterial infections in adults and children, including respiratory infections, skin and soft tissue infections, urinary tract infections, intra-abdominal infections, uncomplicated gonorrhea caused by susceptible <em>Neisseria gonorrhoeae<\/em>, and bacterial meningitis.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:2\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q3\" aria-expanded=\"false\" aria-controls=\"faq-a3\"><span>How does Epirox work?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a3\" role=\"region\" aria-labelledby=\"faq-q3\"><div><p>Ceftriaxone is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis. It shows high penetration into body tissues and fluids, including cerebrospinal fluid.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:3\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q4\" aria-expanded=\"false\" aria-controls=\"faq-a4\"><span>How is Epirox dosed and administered?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a4\" role=\"region\" aria-labelledby=\"faq-q4\"><div><p>Standard dose for adults and children over 12 years: 1G of Ceftriaxone administered once daily or divided into two doses of 500 mg every 12 hours. For severe or critical infections, the dose may be increased to 2-4 G per day. The duration of treatment varies according to the severity and type of infection, but is generally 5 to 14 days. For IV administration, dissolve in sterile solution and administer slowly over at least 30 minutes. For IM administration, dilute in 1% lidocaine to reduce pain at the injection site.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q5\" aria-expanded=\"false\" aria-controls=\"faq-a5\"><span>What are the benefits of Ceftriaxone 1G?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a5\" role=\"region\" aria-labelledby=\"faq-q5\"><div><p>Broad spectrum of antibacterial activity. Convenient once-daily dosing facilitates treatment compliance. Broad-spectrum antibacterial activity against susceptible organisms.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q6\" aria-expanded=\"false\" aria-controls=\"faq-a6\"><span>What are the clinical considerations for Epirox?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a6\" role=\"region\" aria-labelledby=\"faq-q6\"><div><p>Evaluate the sensitivity of the causative microorganism before starting treatment. No dosage adjustment is generally necessary in patients with isolated renal or hepatic impairment. Use caution in patients with significant renal and hepatic dysfunction. Monitor the response to treatment and adjust therapy as necessary.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q7\" aria-expanded=\"false\" aria-controls=\"faq-a7\"><span>What are the safety and precautionary measures for Epirox?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a7\" role=\"region\" aria-labelledby=\"faq-q7\"><div><p>Caution in patients with a history of allergic reactions to beta-lactam antibiotics. Monitor for signs of pseudomembranous colitis and other gastrointestinal adverse reactions. Do not use in hyperbilirubinemic neonates. Ceftriaxone is contraindicated in neonates \u226428 days who require or are expected to require calcium-containing IV solutions.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q8\" aria-expanded=\"false\" aria-controls=\"faq-a8\"><span>Which strength and presentation is available?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a8\" role=\"region\" aria-labelledby=\"faq-q8\"><div><p>Epirox contains Ceftriaxone sodium USP 1.0 g and is presented in a box of 10 and 50 vials, following the United States Pharmacopeia standard.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q9\" aria-expanded=\"false\" aria-controls=\"faq-a9\"><span>How is Epirox manufactured?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a9\" role=\"region\" aria-labelledby=\"faq-q9\"><div><p>Manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality. Crassula Pharma certifies that all our products are manufactured in accordance with GMP parameters.<\/p><\/div><\/div>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"quality\" id=\"quality\" aria-labelledby=\"qs\">\n  <div class=\"cx-wrap\">\n    <div class=\"qbox rv\">\n      <h2 id=\"qs\">Quality &amp; Standards<\/h2>\n      <div class=\"qgrid\">\n        <img decoding=\"async\" class=\"gmp\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/logo-gmp.png\" alt=\"GMP Certified Quality\" width=\"112\" height=\"112\" title=\"\">\n        <div class=\"check\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9.5\"\/><path d=\"m8 12.5 2.7 2.7L16 9.5\"\/><\/svg><p>Manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality.<\/p><\/div>\n        <div class=\"check\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9.5\"\/><path d=\"m8 12.5 2.7 2.7L16 9.5\"\/><\/svg><p>Crassula Pharma certifies that all our products are manufactured in accordance with GMP parameters.<\/p><\/div>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/section>\n<\/main>\n\n\n<script>\n(function(){\n  var d=document.documentElement,b=document.body;\n  b.classList.remove('no-js');\n  requestAnimationFrame(function(){requestAnimationFrame(function(){b.classList.add('loaded')})});\n\n  var io=new IntersectionObserver(function(es){es.forEach(function(e){\n    if(e.isIntersecting){e.target.classList.add('in');io.unobserve(e.target)}})},{threshold:.15,rootMargin:'0px 0px -6% 0px'});\n  document.querySelectorAll('.rv').forEach(function(el){io.observe(el)});\n\n\n  (function(){\n    var c=document.getElementById('fx');if(!c||!c.getContext)return;\n    var ctx=c.getContext('2d'),hero=c.parentElement,W=0,H=0,dpr=1,P=[],run=false,raf=0,mx=-999,my=-999;\n    var reduce=matchMedia('(prefers-reduced-motion: reduce)').matches;\n    function size(){var r=hero.getBoundingClientRect();dpr=Math.min(devicePixelRatio||1,2);W=r.width;H=r.height;c.width=W*dpr;c.height=H*dpr;ctx.setTransform(dpr,0,0,dpr,0,0);\n      var n=Math.round(Math.min(90,Math.max(28,W*H\/16000)));P=[];\n      for(var i=0;i<n;i++)P.push({x:Math.random()*W,y:Math.random()*H,vx:(Math.random()-.5)*.28,vy:(Math.random()-.5)*.28,r:Math.random()*1.4+.8});}\n    function draw(){\n      ctx.clearRect(0,0,W,H);var L=Math.min(150,W\/7);\n      for(var i=0;i<P.length;i++){var a=P[i];\n        if(!reduce){a.x+=a.vx;a.y+=a.vy;if(a.x<0||a.x>W)a.vx*=-1;if(a.y<0||a.y>H)a.vy*=-1;\n          var dx=a.x-mx,dy=a.y-my,d=dx*dx+dy*dy;if(d<14400){var f=(1-Math.sqrt(d)\/120)*.6;a.x+=dx*f*.02;a.y+=dy*f*.02}}\n        for(var j=i+1;j<P.length;j++){var b=P[j],ex=a.x-b.x,ey=a.y-b.y,e=ex*ex+ey*ey;\n          if(e<L*L){ctx.strokeStyle='rgba(224,196,236,'+(.22*(1-Math.sqrt(e)\/L))+')';ctx.lineWidth=1;ctx.beginPath();ctx.moveTo(a.x,a.y);ctx.lineTo(b.x,b.y);ctx.stroke()}}\n        ctx.fillStyle='rgba(240,222,247,.75)';ctx.beginPath();ctx.arc(a.x,a.y,a.r,0,6.2832);ctx.fill();}\n      if(run&&!reduce)raf=requestAnimationFrame(draw);}\n    function start(){if(!run){run=true;raf=requestAnimationFrame(draw)}}\n    function stop(){run=false;cancelAnimationFrame(raf)}\n    size();draw();\n    var rt;addEventListener('resize',function(){clearTimeout(rt);rt=setTimeout(function(){size();draw()},150)});\n    hero.addEventListener('pointermove',function(e){var r=hero.getBoundingClientRect();mx=e.clientX-r.left;my=e.clientY-r.top},{passive:true});\n    hero.addEventListener('pointerleave',function(){mx=my=-999});\n    new IntersectionObserver(function(es){es[0].isIntersecting?start():stop()}).observe(hero);\n  })();\n\n  document.querySelectorAll('.faq-q').forEach(function(b){\n    b.addEventListener('click',function(){\n      var it=b.closest('.faq-item'),open=it.classList.toggle('open');\n      b.setAttribute('aria-expanded',open?'true':'false');\n    });\n  });\n  var flow=document.getElementById('flow');\n  var fio=new IntersectionObserver(function(es){es.forEach(function(e){if(e.isIntersecting){flow.classList.add('in');fio.disconnect()}})},{threshold:.25});\n  fio.observe(flow);\n\n  var steps=document.getElementById('steps');\n  function line(){var r=steps.getBoundingClientRect(),h=innerHeight;\n    var p=Math.min(1,Math.max(0,(h*.75-r.top)\/r.height));steps.style.setProperty('--line',p)}\n  addEventListener('scroll',line,{passive:true});line();\n\n})();\n<\/script>\n<\/body>\n<\/html>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Epirox (Ceftriaxone sodium) \u2013 Crassula Skip to content Cephalosporin \u00b7 Powder for Injectable Solution I.V. \/ I.M. Epirox Ceftriaxone sodium 1 g Pharmacological Properties Active ingredient Ceftriaxone sodium USP Strength 1.0 g Presentation Box of 10 and 50 vials Standard USP What is Epirox? Ceftriaxone 1G (Ceftriaxone Sodium) for Intravenous and Intramuscular Use. Product Description [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-11872","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/11872","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/comments?post=11872"}],"version-history":[{"count":4,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/11872\/revisions"}],"predecessor-version":[{"id":11879,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/11872\/revisions\/11879"}],"wp:attachment":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/media?parent=11872"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}